Phentolamine (Mesylate) Overview Categories 12 Cardiovascular drugs12.3 Anti-hypertensives12.3.5 Alpha-1 receptor antagonists Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Lacidipine Manufacturers of Lacidipine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Lacidipine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 0.071 mg/kg0.071 (0.071)As recommended.IMAs Required0.071 mg/kg0.071 (0.071)As recommended.IVAs Required Paedriatic Dosage (20kg) 0.1 to 0.5 mg/kg0.3 (0.3)As recommended.Intra VenousSingle Dose, As Required Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Lacidipine is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Lacidipine Back to top Manufacturers of Phentolamine (Mesylate) in Pakistan Back to top Previous Drug Generic - Next Drug Generic
Phentolamine (Mesylate) Overview Categories 12 Cardiovascular drugs12.3 Anti-hypertensives12.3.5 Alpha-1 receptor antagonists Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Lacidipine Manufacturers of Lacidipine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Lacidipine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 0.071 mg/kg0.071 (0.071)As recommended.IMAs Required0.071 mg/kg0.071 (0.071)As recommended.IVAs Required Paedriatic Dosage (20kg) 0.1 to 0.5 mg/kg0.3 (0.3)As recommended.Intra VenousSingle Dose, As Required Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Lacidipine is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Lacidipine Back to top Manufacturers of Phentolamine (Mesylate) in Pakistan Back to top Previous Drug Generic - Next Drug Generic